Evidence map›Paper›PMID 41395318›Full record

ArticleIJTLD open2025

Proceedings from the Third International Post-Tuberculosis Symposium: expanding the circle.

B W Allwood, S C Auld, B Beko, G P Bisson, C P Borges de Almeida, A Byrne, F C Chow, A Davis, S Defres, M Drage and 26 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJTLD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

B W AllwoodDivision of Pulmonology, Department of Medicine, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
S C AuldDepartments of Medicine, Epidemiology and Global Health, School of Medicine and Rollins School of Public Health, Emory University, Atlanta, GA, USA.
B BekoTB Proof, Cape Town, South Africa.
G P BissonDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
C P Borges de AlmeidaFaculty of Public Health, Federal University of Sul e Sudeste do Pará, Marabá, Brazil.
A ByrneDepartment of Thoracic Medicine, St Vincent's Hospital and Clinical School, University of New South Wales, Sydney, NSW, Australia.
F C ChowDepartments of Neurology and Medicine, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
A DavisThe Francis Crick Institute, London, UK.
S DefresTropical and Infectious Diseases Unit, Liverpool University Hospitals Foundation NHS Trust, Liverpool, UK.
M DrageLHL International Tuberculosis Foundation, Oslo, Norway.
D EvansHealth Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
X GaiDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
G GüntherDepartment of Pulmonology, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
A N GupteBoston University School of Public Health, Boston, MA, USA.
G HoddinottDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
M A HuamanDepartment of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
S HuddartDepartment of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, San Francisco, CA, USA.
J HuynhOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
G KalyatandaDivision of Infectious Disease and Global Medicine, Department of Medicine, University of Florida College of Medicine, Gainesville, FL, USA.
C KhosaInstituto Nacional de Saúde, Marracuene, Mozambique and Department of Physiological Sciences, Clinical Pharmacology, Faculty of Medicine, Universidade Eduardo Mondlane, Maputo, Mozambique.
T KutadzaZimbabwe National Network of PLHIV, Harare, Zimbabwe.
G MakandaTB Proof, Cape Town, South Africa.
S MaraisDivision of Neurology, Department of Medicine and Neurology Research Group, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
J MeghjiNational Heart and Lung Institute, Imperial College London, London, UK.
N NavuluriDepartment of Medicine, Duke University School of Medicine and Duke Global Health Institute, Durham, NC, USA.
E NkereuwemVaccines and Immunity Theme, Medical Research Council Unit, The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
A RajaratnamDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
K RomanowskiDepartment of Global and Public Health, McGill University, Montreal, QC, Canada.
I SchoemanTB Proof, Cape Town, South Africa.
J A SeddonDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
H SohnDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
F ThienemannGeneral Medicine and Global Health Research Unit, Department of Medicine, University of Cape, Cape Town, South Africa.
D T WademanDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
N F WalkerTropical and Infectious Diseases Unit, Liverpool University Hospitals Foundation NHS Trust, Liverpool, UK.
M M van der ZalmDesmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
R NightingaleCentre for Tuberculosis Research and Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.

Funding

Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Jeffrey M Collins · 2022 to 2026
$5.8M
NIAID NIH HHS P30 AI168386
6 · The paper itself

Abstract

In light of the recent growth in interest and knowledge of post-TB sequelae, there were high levels of engagement during the 3rd International Post-Tuberculosis Symposium held in Stellenbosch, South Africa. This multi-disciplinary symposium aimed to: 1) Advocate for greater global awareness of post-TB sequelae and empower TB-affected communities; 2) Advance knowledge by sharing current evidence and identifying key priorities; 3) Foster collaborations by strengthening research networks and developing concrete plans for research driven advocacy; and 4) Advance the field by establishing areas of consensus around diagnosis, care, and management. Guided by a 14-member Steering Committee, 9 academic working groups came together to develop key content for plenary sessions and facilitated workshops related to: Patient Engagement, Epidemiology and Modelling, Pathogenesis, Post-TB Lung Disease; Cardiovascular and Pulmonary Vascular Disease; Central Nervous System and Musculoskeletal Disease; Paediatrics Economic; Social and Psychological Sequelae; and Advocacy, Policy, and Stakeholder Engagement. Each group outlined progress within their respective fields and defined key priorities to focus discussion. The Symposium further catalysed coordinated action for the post-TB community of patients, advocates, clinicians, and researchers to define a clear path towards improving outcomes, reducing inequities, and ensuring TB survivors receive the care and support they deserve.

Indexed as

advocacypost-TB lung healthsequelaetuberculosis

Identifiers

PMID41395318
PMCPMC12699966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.